Federal officials say that Metformin may contain a carcinogen

Share on facebook
Share on twitter
Share on linkedin

The U.S. Food and Drug Administration (FDA) confirmed earlier this month that they are looking into reports that researchers in other countries have found trace amounts of the carcinogen N-Nitrosodimethylamine (NDMA) in the prescription drug Metformin. The medication is commonly prescribed to patients who have previously been diagnosed with Type 2 Diabetes. It helps them regulate their blood sugar.

NDMA is a contaminate that is often found in grilled or cured meats, dairy products, water and vegetables. While scientists don’t believe that the carcinogen poses any adverse health risk if individuals are exposed to it in small doses, they believe that it is dangerous if a person ingests any amount of the substance above the daily limit for an extended period.

So far Metformin has been recalled by public health officials in many of the countries where the medication was found to have contained trace amounts of NDMA.

The FDA announced earlier this month that they haven’t decided whether to recall the drug. Their spokesperson noted that the federal agency’s decision will be largely contingent upon how much of the carcinogen the prescription drug is found to contain. FDA regulators point out that the daily limit for the contaminate is 96 nanograms. If they find that it contains less than that, then it’s likely that it will continue to be made available to patients.

Millions of Americans living in the U.S. are either pre-diabetic or already have been diagnosed with Type 2 diabetes. Many of them are taking the popular medication Metformin. Individuals who experience a health decline while on this prescription drug may be entitled to compensation for their medical costs and related expenses. An attorney can advise you of your right to file suit in your case.

Contact Us For a Free Legal Consultation

There is a never a fee unless we recover on your behalf.